PEAK6
LFST icon

PEAK6’s Lifestance Health LFST Stock Holding History

PEAK6’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Buy
+400,000
New +$3.09M 0.01% 918
2025
Q1 		– Sell
-101,300
Closed -$747K – 3337
2024
Q4 		$747K Buy
+101,300
New +$727K ﹤0.01% 1954

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

PEAK6's LFST Position: Q2 2026 in Review

PEAK6 sold out of Lifestance Health (LFST) in Q2 2026, closing a stake of 15,402 shares — an estimated $119K sold.

PEAK6 first reported a position in LFST in Q4 2024 and held it in 2 quarters. The position peaked at $156K in Q4 2024. 289 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • PEAK6 reported no remaining Lifestance Health position as of Q2 2026 after selling out during the quarter.
  • PEAK6 sold 15,402 Lifestance Health shares in Q2 2026, an estimated $119K.
  • PEAK6 first reported a position in Lifestance Health in Q4 2024 and held it in 2 quarters.
  • PEAK6's Lifestance Health position peaked at $156K in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.